Literature DB >> 25246833

Histopathological Study of the Lungs of Mice Receiving Human Secretory IgA and Challenged with Mycobacterium tuberculosis.

Nadine Alvarez1, Juan Francisco Infante1, Reinier Borrero1, Dulce Mata2, Jorge Barrios- Payan2, Md Murad Hossain3, Norazmi Mohd Nor3, María Elena Sarmiento1, Rogelio Hernandez-Pando2, Armando Acosta1.   

Abstract

BACKGROUND: Humoral and cellular immune responses are associated with protection against extracellular and intracellular pathogens, respectively. In the present study, we evaluated the effect of receiving human secretory immunoglobulin A (hsIgA) on the histopathology of the lungs of mice challenged with virulent Mycobacterium tuberculosis.
METHODS: The hsIgA was purified from human colostrum and administered to Balb/c mice by the intranasal route prior to infection with M. tuberculosis or in a pre-incubated formulation with mycobacteria, with the principal aim to study its effect on qualitative pulmonary histopathology.
RESULTS: The intranasal administration of hsIgA and the pre-incubation of mycobacteria with this preparation was associated with the presence of organised granulomas with signs of immune activation and histological features related to efficient disease control. This effect was highly evident during the late stage of infection (60 days), as demonstrated by numerous organised granulomas with numerous activated macrophages in the lungs of treated mice.
CONCLUSION: The administration of hsIgA to mice before intratracheal infection with M. tuberculosis or the pre-incubation of the bacteria with the antibody formulation induced the formation of well-organised granulomas and inflammatory lesions in lungs compared with non-treated animals which correlates with the protective effect already demonstrated by these antibody formulations.

Entities:  

Keywords:  Mycobacterium tuberculosis; colostrums; secretory immunoglobulin A

Year:  2014        PMID: 25246833      PMCID: PMC4163556     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  34 in total

1.  IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection.

Authors:  B P Arulanandam; R H Raeder; J G Nedrud; D J Bucher; J Le; D W Metzger
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  A mucosal IgA-mediated excretory immune system in vivo.

Authors:  J K Robinson; T G Blanchard; A D Levine; S N Emancipator; M E Lamm
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

3.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 4.  The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.

Authors:  Aharona Glatman-Freedman
Journal:  Tuberculosis (Edinb)       Date:  2006-04-03       Impact factor: 3.131

5.  Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis.

Authors:  R Hernandez-Pando; T Schön; E H Orozco; J Serafin; I Estrada-García
Journal:  Exp Toxicol Pathol       Date:  2001-09

6.  Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis.

Authors:  R Hernandez-Pando; H Orozco; K Arriaga; A Sampieri; J Larriva-Sahd; V Madrid-Marina
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

7.  Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.

Authors:  S de Vallière; G Abate; A Blazevic; R M Heuertz; D F Hoft
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection.

Authors:  R Reljic; S O Clark; A Williams; G Falero-Diaz; M Singh; S Challacombe; P D Marsh; J Ivanyi
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 9.  Mucosal immunotherapy of tuberculosis: is there a value in passive IgA?

Authors:  Rajko Reljic; Ann Williams; Juraj Ivanyi
Journal:  Tuberculosis (Edinb)       Date:  2006-02-28       Impact factor: 3.131

10.  Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection.

Authors:  Yamilé López; Daniel Yero; Gustavo Falero-Diaz; Nesty Olivares; María E Sarmiento; Sergio Sifontes; Rosa L Solis; Jorge A Barrios; Diana Aguilar; Rogelio Hernández-Pando; Armando Acosta
Journal:  Int J Med Microbiol       Date:  2009-01-20       Impact factor: 3.473

View more
  2 in total

Review 1.  B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.

Authors:  Martin Rao; Davide Valentini; Thomas Poiret; Ernest Dodoo; Shreemanta Parida; Alimuddin Zumla; Susanna Brighenti; Markus Maeurer
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

2.  Evaluation of in vivo antimycobacterial activity of some folklore medicinal plants and enumeration of colony forming unit in murine model.

Authors:  Acheenta Gohain Barua; Himangshu Raj; Pranab Konch; P Hussain; Chandana C Barua
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.